How Proximity Creates Partnerships
VC Playbook: Sean Harper’s Bet On A Rising City Of Angels
21 Oct 2019 INTERVIEWS
by William Looney @BillInVivo email@example.com
Former Amgen R&D lead Sean Harper talks exclusively to In Vivo about his new role as a venture capitalist, joining veteran industry investor Beth Seidenberg as co-founder of Los Angeles-based Westlake Village BioPartners.
Reprinted with permission from
We are happy to announce an open call for UCLA’s second cohort of Faculty Innovation Fellows (FIF). Started by the Technology Development Group, the Office of Research and Creative Activities, and Startup UCLA, the Faculty Innovation Fellows is a program aimed at advancing entrepreneurial excellence and startup culture among faculty across campus. A UCLA Newsroom story about last year’s program can be found here.
U.S. Patent Office to Issue Patent for Detecting Traumatic Brain Injury (TBI) Using Aldolase C
The Notice of Allowance issued by the PTO to The Regents of the University of California through UCLA
Technology Development Group indicates that another U.S. patent, exclusively licensed to BRAINBox
Solutions, will be issued to protect the biomarker panels to be used by BRAINBox Solutions in its pointof-
care products that detect TBI and monitor patient recovery. BRAINBox Solutions previously obtained
UCLA signed a license agreement with Theseus AI for technology developed at UCLA that uses artificial intelligence to interpret MRI scans of patients’ spines.
In this this issue we are happy to feature our spinout companies and recent initiatives like Faculty Innovation Fellow program and Bioscience Innovation Day 2019. Plus, you can read about our recent successes in outreach and licensing.
Is Los Angeles The Go-To Destination For Tomorrow’s Drug Innovations?
In Vivo sits down with eight key leaders in academia, VC, commercial real estate and groundbreaking biotech to discuss how Los Angeles – the “out there” city of out-sized ambitions – is positioning itself for global leadership in the curative technologies of the future.
Bone Biologics Receives Human Research Ethics Committee (HREC) Approval for the First Center of a Multicenter Pilot Clinical Trial to Evaluate NB1 (NELL-1/DBX®) in Australia
UCLA Technology Development Group is pleased to present the December 2018 issue of Innovation Magazine.